The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer
OncoImmunology - United States
doi 10.4161/onci.25997
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2013
Authors
Publisher
Informa UK Limited